Related Experiment Video

Updated: Mar 30, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.5K

The future of pharmacogenetics in the treatment of heart failure

Mohamed Subhan Anwar1, Muhammad Zaid Iskandar1, Helen M Parry2

  • 1Division of Cardiovascular & Diabetes Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.

Pharmacogenomics
|November 12, 2015
PubMed

Insights

Identifying genetic factors in heart failure treatment response is crucial. Future research using advanced genetic approaches may enable personalized medicine for improved patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacogenetics
  • Genomics

Background:

  • Heart failure (HF) presents significant morbidity and mortality.
  • Current HF treatments include beta-blockers, ACE inhibitors, aldosterone antagonists, and diuretics.
  • Observed variations in patient response suggest a potential pharmacogenetic component.

Purpose of the Study:

  • To explore the pharmacogenetic basis of variable clinical responses to heart failure medications.
  • To identify genetic variations that influence the efficacy and safety of heart failure therapies.

Main Methods:

  • Review of existing literature on pharmacogenetics in heart failure.
  • Discussion of single nucleotide polymorphisms (SNPs) in adrenergic receptors and the renin-angiotensin-aldosterone pathway.
  • Consideration of genome-wide association studies (GWAS) and next-generation sequencing (NGS) as advanced approaches.

Main Results:

  • Previous studies on specific gene polymorphisms (e.g., adrenergic receptors, RAAS pathway) have yielded inconsistent results.
  • Genome-wide association studies and next-generation sequencing offer promising avenues for comprehensive genetic discovery.
  • The genetic underpinnings of drug response in heart failure remain incompletely understood.

Conclusions:

  • Further investigation into genetic variations is necessary to understand differential drug responses in heart failure.
  • Advanced genomic techniques are essential for uncovering novel genetic markers.
  • The ultimate goal is to facilitate genotype-led drug management for enhanced heart failure patient outcomes.

Keywords:
candidate genesgenome wide association studyheart failurepharmacogeneticspharmacogenomics

More Related Videos

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.2K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.5K

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
144
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
77
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
113
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
95